Ketamine hydrochloride: Clinical Trials

125 trials of Ketamine hydrochloride, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

55 completed, 23 unknown, 22 recruiting, 12 terminated. 41 Phase 2, 33 Phase 3, 22 Phase 4, 16 Not applicable, 15 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 241Completed 20, Recruiting 10, Terminated 5, Active not recruiting 2, Unknown 2, Withdrawn 2
Phase 333Recruiting 11, Completed 8, Unknown 6, Active not recruiting 3, Withdrawn 3, Terminated 2
Phase 422Completed 16, Unknown 4, Recruiting 1, Terminated 1
Not applicable16Unknown 7, Completed 5, Terminated 2, Recruiting 1, Withdrawn 1
Phase 115Completed 5, Unknown 3, Recruiting 2, Terminated 2, Withdrawn 2, Active not recruiting 1
Early Phase 14Completed 2, Terminated 1, Withdrawn 1

Follow Ketamine hydrochloride: new trials by email Literature Review of Ketamine hydrochloride trials Research Report on Ketamine hydrochloride

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Morphine or Ketamine for Analgesia
Ketamine hydrochloride, Morphine sulphate - Abdominal Pain, Isolated Extremity Fracture
Phase 3RecruitingColumbia University10102026-10-172026-10-20
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)
Ketamine Hydrochloride, Midazolam Hydrochloride, Dialectical Behavioral Therapy (DBT) - Borderline Personality Disorder (BPD), Treatment-Resistant Major Depressive Disorder
Phase 2RecruitingJoshua Rosenblat1202026-07-162026-07-29
Ketamine in Severe Traumatic Brain Injury
Ketamine Hydrochloride - Traumatic Brain Injury, Traumatic Encephalopathy
Early Phase 1WithdrawnUniversity of Texas Southwestern Medical Center2026-06-012026-10-07
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients
Ketamine (0.5 mg/kg), Normal Saline (0.9% NaCl) - Critical Illness, Depressive Symptoms
Phase 2RecruitingHospital Italiano de Buenos Aires502026-05-142026-09-02
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
Ketamine hydrochloride, Minimally Enhanced Usual Care, Brief narrative intervention - Chronic Low Back Pain, Depression
Phase 2RecruitingVA Office of Research and Development442025-12-032025-12-18
Ketamine Sedation in the ICU (KANINE) RCT
ketamine hydrochloride, Normal saline placebo - Mechanical Ventilation, Critically Ill Intensive Care Unit Patients
Phase 3RecruitingMcMaster University542025-11-202026-10-22
Analgosedation With Ketamine, Nalbuphine, or Dexmedetomidine for Suture Removal in Children After Cleft Surgery
ketamine, Nalbuphine, Dexmedetomidine - Orofacial Clefts, Cleft Lip and Palate
Not applicableRecruitingUniversity Medical Centre Ljubljana602025-09-012026-01-14
Effect of Different Anesthetic Drugs on Electrocorticography (ECOG).
Fentanyl (IV), Ketamine (0.5 mg/kg) - Epilepsy, Brain Tumor
Phase 3Active not recruitingChildren's Cancer Hospital Egypt 57357882025-08-182025-09-10
Ketamine Augmentation of ECT in Treatment-Resistant Depression
Ketamine Hydrochloride, Placebo - Major Depressive Disorder, Treatment Resistant Depression
Phase 3RecruitingUniversità Vita-Salute San Raffaele302025-07-102026-05-11
A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients
Ketamine Hydrochloride, Placebo - Depression
Phase 2TerminatedMayo Clinic12025-07-072026-08-12
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Clozapine, Esketamine Nasal Product, Escitalopram - Schizophrenia and Related Disorders, Major Depressive Disorder
Phase 3RecruitingDr. Inge Winter12542025-04-272026-01-22
Understanding and Treating Suicidal Ideation With Ketamine
ketamine hydrochloride - Suicidal Ideation, Major Depressive Disorder (MDD)
Phase 2 / Phase 3RecruitingThe Royal's Institute of Mental Health Research362025-04-082026-05-19
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV
Ketamine, Psychotherapy - Methamphetamine Use Disorder
Phase 2CompletedNicky Mehtani, MD, MPH172025-03-042026-08-12
Ketamine for Combined Depression and Alcohol Use Disorder
Ketamine Hydrochloride, Midazolam Hydrochloride - Depression, Alcohol Use Disorder
Phase 1 / Phase 2RecruitingUniversity Hospital of North Norway342025-01-202026-06-23
Ketamine for Methamphetamine Use Disorder
Ketamine Hydrochloride, Midazolam Hydrochloride - Substance Use Disorders, Substance Use
Phase 2CompletedUniversity of Texas Southwestern Medical Center1202024-09-112026-10-27
Imaging Depression in Parkinson's Disease
11C-UCB-J, ketamine hydrochloride - Parkinson's Disease, Major Depressive Disorder
Phase 2RecruitingYale University1202024-09-012026-03-10
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Esketamine Nasal Product, Ketamine Hydrochloride, Esketamine hydrochloride - Major Depressive Disorder, Treatment Resistant Depression
Phase 3RecruitingDr. Inge Winter4182024-08-312025-09-26
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
Ketamine, Naltrexone Pill, Placebo pill - Obsessive-Compulsive Disorder
Phase 2RecruitingStanford University1502024-02-242026-04-24
Predictors of Intravenous Ketamine Response in TRD
Ketamine, Midazolam - Treatment Resistant Depression, Major Depressive Disorder
Phase 3Active not recruitingAbraham Nunes402024-01-192026-05-22
Study of IV Ketamine for Emergency Department Treatment of Adolescent Suicidal Ideation
Ketamine Hydrochloride, Normal saline - Suicidal Ideation, Suicidal Ideas
Not applicableUnknownChildren's Hospital of Eastern Ontario202024-01-152024-06-05

Showing 20 of 125. Sign in to see all of them.

Conditions studied

Depression (24)  ·  Depressive Disorder, Major (22)  ·  Depressive Disorder, Treatment-Resistant (12)  ·  Suicidal Ideation (10)  ·  Bipolar Disorder (9)  ·  Obsessive-Compulsive Disorder (8)  ·  Pain (7)  ·  Suicide (7)  ·  Agnosia (5)  ·  Anxiety Disorders (5)  ·  Depressive Disorder (5)  ·  Pain, Postoperative (5)  ·  Stress Disorders, Post-Traumatic (5)  ·  Chronic Pain (4)  ·  Fractures, Bone (4)

Sponsors

New York State Psychiatric Institute (6)  ·  University of Texas Southwestern Medical Center (5)  ·  Stanford University (4)  ·  Cairo University (3)  ·  Joshua Rosenblat (3)  ·  Massachusetts General Hospital (3)  ·  University Health Network, Toronto (3)  ·  Assiut University (2)  ·  Dr. Inge Winter (2)  ·  Kasr El Aini Hospital (2)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2)  ·  Mayo Clinic (2)  ·  Medical University of South Carolina (2)  ·  The University of Texas Health Science Center, Houston (2)  ·  University of Ottawa (2)

Countries

United States (56)  ·  Canada (21)  ·  Egypt (9)  ·  China (4)  ·  United Kingdom (4)  ·  Austria (2)  ·  France (2)  ·  Israel (2)  ·  Italy (2)  ·  Spain (2)  ·  Turkey (Türkiye) (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Colombia (1)  ·  Czechia (1)

Top investigators

Naveen Poonai, MD (3)  ·  Dawn Ionescu, M.D. (2)  ·  Joshua Rosenblat, MD, MSc (2)  ·  Madhukar Trivedi, MD (2)  ·  Abraham Nunes, MD PhD MBA FRCPC (1)  ·  Ahmed Hasanin, Professor (1)  ·  Alan Peterson, PhD, ABPP (1)  ·  Alberto AZ Zangrillo, MD (1)  ·  Ali M. Abu Dalo, MD (1)  ·  Amy L Drendel, DO, MS (1)  ·  Andreas W Blomkvist, M.D. (1)  ·  Anna Bashmakov, D.O. (1)  ·  Annabelle Belcher, PhD (1)  ·  Anshi Wu Wu, Ph.D (1)

Results publications

PMID 39428602, PMID 10966311, PMID 12873568, PMID 16703233, PMID 17338847, PMID 18274461, PMID 18790440, PMID 21263301, PMID 21527129, PMID 21563653, PMID 23403253, PMID 23783065, PMID 24131410, PMID 25448584, PMID 25478364, PMID 25535501, PMID 26104826, PMID 26871805, PMID 27046314, PMID 27219513, PMID 27829367, PMID 27871770, PMID 28025837, PMID 29167877, PMID 29923953, PMID 30157913, PMID 30724832, PMID 30922101, PMID 30999057, PMID 31082965, PMID 32300671, PMID 32757505, PMID 32898698, PMID 33031861, PMID 33084081, PMID 33407719, PMID 34034067, PMID 34193480, PMID 34633992, PMID 34971723, PMID 35141873, PMID 35267254, PMID 35448950, PMID 35931041, PMID 36419181, PMID 36570810, PMID 36855160, PMID 36889160, PMID 37194253, PMID 37997749

NIH funding

2023 (2), 2016 (1), 2KL2TR001870 (1), IK2CX002646-01A2 (1), K12DA031794 (1), K23MH092434 (1), K23MH107776 (1), KL2TR003168 (1), R01MH123142 (1), R01MH125181 (1), R01MH125214 (1), R01MH133553 (1), R01NS125482 (1), U01HD116253 (1), UL1TR002645 (1)